DES MOINES, Iowa, 2017-Mar-31 — /EPR Retail News/ — Today (March 29, 2017), CVS Health officials (NYSE: CVS) joined Iowa Lt. Gov. Kim Reynolds, Department of Public Health Director Gerd Clabaugh and Office of Drug Control Policy Director Steve Lukan in announcing the availability of the opioid overdose-reversal medicine naloxone without a prescription at all…
WOONSOCKET, R.I., 2016-Oct-03 — /EPR Retail News/ — CVS Health (NYSE: CVS) today (September 29, 2016) announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription. In total, CVS Pharmacy patients in 36 states now…
WOONSOCKET, R.I., 2016-Aug-02 — /EPR Retail News/ — CVS Health (NYSE: CVS) and Adapt Pharma (www.AdaptPharma.com) today announced a new partnership that will make the opioid overdose-reversing drug NARCAN (Naloxone HCl) Nasal Spray more affordable for patients without insurance at CVS Pharmacy locations. Through this partnership, CVS Pharmacy patients purchasing NARCAN Nasal Spray without insurance will…